BTI
GMAB icon

Blue Trust Inc’s Genmab GMAB Stock Holding History

Blue Trust Inc’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$321K Buy
11,676
+67
+0.6% +$1.78K ﹤0.01% 640
2026
Q1 		$311K Sell
11,609
-130
-1% -$3.9K ﹤0.01% 638
2025
Q4 		$362K Sell
11,739
-544
-4% -$17K ﹤0.01% 591
2025
Q3 		$377K Buy
12,283
+2,412
+24% +$58.8K ﹤0.01% 591
2025
Q2 		$204K Buy
9,871
+2,458
+33% +$50.5K ﹤0.01% 765
2025
Q1 		$145K Buy
7,413
+4,666
+170% +$97.9K ﹤0.01% 836
2024
Q4 		$57.3K Sell
2,747
-1,568
-36% -$34.5K ﹤0.01% 1228
2024
Q3 		$108K Buy
4,315
+3,880
+892% +$104K ﹤0.01% 1180
2024
Q2 		$13K Buy
435
+238
+121% +$6.75K ﹤0.01% 1832
2024
Q1 		$5.89K Sell
197
-646
-77% -$19K ﹤0.01% 1594
2023
Q4 		$30K Buy
843
+230
+38% +$7.22K ﹤0.01% 1135
2023
Q3 		$23K Buy
613
+70
+13% +$2.67K ﹤0.01% 1128
2023
Q2 		$20K Sell
543
-495
-48% -$19.7K ﹤0.01% 1042
2023
Q1 		$44K Buy
1,038
+198
+24% +$7.61K ﹤0.01% 1084
2022
Q4 		$27K Buy
840
+635
+310% +$26.2K ﹤0.01% 1174
2022
Q3 		$6K Buy
205
+87
+74% +$3.06K ﹤0.01% 1512
2022
Q2 		$4K Buy
+118
New +$3.82K ﹤0.01% 1499

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Blue Trust Inc's GMAB Position: Q2 2026 in Review

Blue Trust Inc increased its Genmab (GMAB) stake by 0.58% in Q2 2026, buying an estimated $1.78K and bringing the position to 11,676 shares worth $321K. The position accounts for ﹤0.01% of the portfolio, ranked #640.

Blue Trust Inc first reported a position in GMAB in Q2 2022 and has held it in 17 quarters since. The position peaked at $377K in Q3 2025. 290 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Blue Trust Inc held 11,676 shares of Genmab worth $321K as of Q2 2026.
  • Blue Trust Inc bought 67 Genmab shares in Q2 2026, an estimated $1.78K.
  • Genmab made up ﹤0.01% of Blue Trust Inc's portfolio in Q2 2026, its #640 holding.
  • Blue Trust Inc first reported a position in Genmab in Q2 2022 and has held it in 17 quarters since.
  • Blue Trust Inc's Genmab position peaked at $377K in Q3 2025.
  • 290 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.